Skip to content

Educational only — not medical advice. If you’re in crisis or thinking about suicide: call or text 988 (U.S.) or your local emergency number. Support resources.

PsychMed

Site updates

A running log of data refreshes, structured data tweaks, and new educational content rolling out on PsychMed.

Subscribe via RSS

Added milsaperidone (Bysanti) — new FDA-approved antipsychotic

Added milsaperidone (Bysanti), a second-generation antipsychotic approved Feb 2026 for schizophrenia and acute manic/mixed episodes in bipolar I disorder. Includes full drug profile, evidence entries, and compare-table integration.

Added GLP-1 metabolic meds (Ozempic/Wegovy/Mounjaro/Zepbound) + evidence + glossary terms

Added GLP-1 metabolic meds (Ozempic/Wegovy/Mounjaro/Zepbound) + evidence + glossary terms

Substance-use treatment + harm-reduction profiles added

Added new medication guides covering opioid, alcohol, and tobacco use disorders, including buprenorphine, buprenorphine-naloxone, methadone, naltrexone (oral and extended-release), naloxone rescue, lofexidine, acamprosate, disulfiram, nicotine replacement therapy, and varenicline.

Add propranolol, gabapentin, pregabalin profiles

Add propranolol, gabapentin, pregabalin profiles

Added temazepam, triazolam, oxazepam, chlordiazepoxide

Added temazepam, triazolam, oxazepam, chlordiazepoxide

Sleep & anxiety coverage expanded + evidence library refreshed

Added new medication guides (alprazolam, diazepam, eszopiclone, prazosin, zolpidem, ramelteon, suvorexant, lemborexant, daridorexant, zaleplon), populated the Evidence library with curated guidelines/trials/meta-analyses, and refreshed Support hub resource links.

Antidepressant profile collection completed

Sertraline, tranylcypromine, venlafaxine, vilazodone, and vortioxetine now have the same full guides as our antipsychotic pages—plain-language overviews, key dosing tips, printable takeaways, and quick comparison notes.

Antidepressant and MAOI coverage added

We brought the SSRI/SNRI group, atypical antidepressants, and MAOIs online. Each page now lists brand names, fresh DailyMed links, and practical monitoring reminders so you can compare options at a glance.

Mood stabilizers and VMAT2 inhibitors onboarded

Lithium, valproate, carbamazepine, lamotrigine, oxcarbazepine, valbenazine, and deutetrabenazine now feature clear safety checklists, DailyMed label links, and level-monitoring guidance to support everyday prescribing decisions.

Core antipsychotic catalog published

Our launch covers haloperidol, risperidone, paliperidone, olanzapine, quetiapine, brexpiprazole, cariprazine, lurasidone, lumateperone, ziprasidone, asenapine, and clozapine. Each profile includes balanced dosing ranges, safety watch-outs, and direct label links.